Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 9:10 PM View:  | Irish Jian See Remarks Director | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 70,471 | -- | -- | 12% 585.43K to 655.9K | |
| 03-Apr-24 8:18 PM View: | Delaney Simren See Remarks | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 6,931 | -- | -- | 8% 86.96K to 93.89K | |
| 03-Apr-24 8:52 PM View: | Wapnick Pamela Chief Financial Officer | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 69,316 | -- | -- | 100% 0 to 69.32K | |
| 03-Apr-24 8:00 PM View: | Thomas Brian C. Chief Executive Officer Director | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 118,992 | -- | -- | 5% 2.38M to 2.5M | |
| 03-Apr-24 8:40 PM View: | Harnest Simon See Remarks | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 11,552 | -- | -- | 10% 111.11K to 122.66K | |
| 03-Apr-24 8:59 PM View: | Borges Luis Chief Scientific Officer | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 69,316 | -- | -- | 100% 0 to 69.32K | |
| 03-Apr-24 8:57 PM View: | Wein Matthew See Remarks | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 10,397 | -- | -- | 100% 0 to 10.4K | |
| 03-Apr-24 8:47 PM View: | Noonberg Sarah B. Chief Medical Officer | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 57,763 | -- | -- | 136% 42.61K to 100.37K | |
| 14-Feb-24 4:29 PM View: | Bernales Sebastian Director | Metagenomi, Inc. (MGX) | 13-Feb-24 | Conversion | 1,896,440 | -- | -- | 162% 1.17M to 3.07M | |
| 15-Feb-24 8:38 PM View: | Novo A/s 10% Owner | Metagenomi, Inc. (MGX) | 13-Feb-24 | Purchase | 800,000 | $15.00 | $12,000,000.00 | 85% 939.18K to 1.74M | |
| 15-Feb-24 8:38 PM View: | Novo A/s 10% Owner | Metagenomi, Inc. (MGX) | 13-Feb-24 | Conversion | 839,175 | -- | -- | 839% 100.0K to 939.17K | |
| 15-Feb-24 5:59 PM View: | Bayer Healthcare LLC 10% Owner | Metagenomi, Inc. (MGX) | 13-Feb-24 | Conversion | 4,051,000 | -- | -- | 100% 0 to 4.05M | |
| 14-Feb-24 4:29 PM View: | Bernales Sebastian Director | Metagenomi, Inc. (MGX) | 13-Feb-24 | Conversion | 513,004 | -- | -- | 78% 659.34K to 1.17M | |
| 15-Feb-24 8:38 PM View: | Novo A/s 10% Owner | Metagenomi, Inc. (MGX) | 09-Feb-24 | Purchase | 100,000 | $10.25 | $1,025,000.00 | 100% 0 to 100.0K |
